Instituto de Salud Pública de Navarra, Leyre 15, 31003 Pamplona, Spain; CIBER Epidemiología y Salud Pública, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Clinical Microbiology Department, Hospital Universitario de Navarra, Irunlarrea, 31008 Pamplona, Spain.
J Infect Public Health. 2023 Mar;16(3):410-417. doi: 10.1016/j.jiph.2023.01.017. Epub 2023 Jan 25.
COVID-19 vaccination was expected to reduce SARS-CoV-2 transmission, but the relevance of this effect remains unclear. We aimed to estimate the effectiveness of COVID-19 vaccination of the index cases and their close contacts in reducing the probability of SARS-CoV-2 transmission.
Transmission of SARS-CoV-2 infection was evaluated in two cohorts of adult close contacts of COVID-19 confirmed cases (social and household settings) by COVID-19 vaccination status of the index case and the close contact, from April to November 2021 in Navarre, Spain. The effects of vaccination of the index case and the close contact were estimated as (1-adjusted relative risk) × 100%.
Among 19,631 social contacts, 3257 (17%) were confirmed with SARS-CoV-2. COVID-19 vaccination of the index case reduced infectiousness by 44% (95% CI, 27-57%), vaccination of the close contact reduced susceptibility by 69% (95% CI, 65-73%), and vaccination of both reduced transmissibility by 74% (95% CI, 70-78%) in social settings, suggesting some synergy of effects. Among 20,708 household contacts, 6269 (30%) were infected, and vaccine effectiveness estimates were 13% (95% CI, -5% to 28%), 61% (95% CI, 58-64%), and 52% (95% CI, 47-56%), respectively. These estimates were lower in older people and had not relevant differences between the Alpha (April-June) and Delta (July-November) variant periods.
COVID-19 vaccination reduces infectiousness and susceptibility; however, these effects are insufficient for complete control of SARS-CoV-2 transmission, especially in older people and household setting. Relaxation of preventive behaviors after vaccination may counteract part of the vaccine effect on transmission.
预计 COVID-19 疫苗接种可降低 SARS-CoV-2 的传播,但这种效果的相关性仍不清楚。我们旨在估计 COVID-19 确诊病例的索引病例及其密切接触者接种疫苗,以降低 SARS-CoV-2 传播的概率。
从 2021 年 4 月至 11 月,在西班牙纳瓦拉,通过 COVID-19 确诊病例的密切接触者的 COVID-19 疫苗接种状况,评估了社交和家庭环境中成年密切接触者的 SARS-CoV-2 感染传播情况。通过接种指数病例和密切接触者疫苗的(1-调整后的相对风险)×100%,估计了接种的效果。
在 19631 名社交接触者中,有 3257 名(17%)被确诊患有 SARS-CoV-2。在社交环境中,索引病例接种疫苗可降低传染性 44%(95%CI,27-57%),密切接触者接种疫苗可降低易感性 69%(95%CI,65-73%),两者同时接种可降低传播率 74%(95%CI,70-78%),表明存在协同作用。在 20708 名家庭接触者中,有 6269 人(30%)感染,疫苗有效性估计值分别为 13%(95%CI,-5%至 28%)、61%(95%CI,58-64%)和 52%(95%CI,47-56%)。在老年人中,这些估计值较低,并且在 Alpha(4 月至 6 月)和 Delta(7 月至 11 月)变体期间,没有发现相关差异。
COVID-19 疫苗接种可降低传染性和易感性;然而,这些效果不足以完全控制 SARS-CoV-2 的传播,尤其是在老年人和家庭环境中。接种疫苗后放松预防行为可能会部分抵消疫苗对传播的影响。